Objective: Dogma discourages the provision of topical anes thetics to patients with corneal injuries discharged from the emergency department because of the toxicity of concen trated solutions. We compared the analgesic efficacy of dilute topical proparacaine with placebo in emergency department patients with acute corneal injuries. Methods: We conducted a prospective randomized controlled trial of adults with corneal injuries presenting to one of 2 tertiary care emergency departments in London, Ont. Patients were ran domly assigned to groups receiving either 0.05% proparacaine or placebo drops as outpatients and were followed up to heal ing by a single ophthalmologist. Our primary outcome was pain reduction as measured on a 10cm visual analog scale. Results: Fifteen participants from the proparacaine group and 18 participants from the placebo group completed the study. The mean age of the patients was 38.7 (standard deviation 12.3) years and the majority were male (85%). Pain reduction was significantly better in the proparacaine group than in the placebo group, with a median improvement of 3.9 (interquar tile range [IQR] 1.5-5.1) cm on the visual analog scale versus a median improvement of 0.6 (IQR 0.2-2.0) cm (p = 0.007). The proparacaine group was more satisfied (median level of satis faction 8.0 .0] cm on a 10cm visual analog scale v. 2.6 [IQR 1.0-8.0] cm, p = 0.027). There were no ocular compli cations or signs of delayed wound healing in either group. Conclusion: Dilute topical proparacaine is an efficacious anal gesic for acute corneal injuries. Although no adverse events were observed in our study population, larger studies are required to evaluate safety.
INTRODUCTION
Acute corneal injuries are a common complaint in the emergency department. They cause significant patient morbidity, including pain, loss of sleep and missed work. The approach to pain management varies in this patient population and includes the following: no anal gesia, oral or topical nonsteroidal antiinflammatory drugs (NSAIDs), oral opiates and cycloplegics. 1 Topical agents can reduce pain; however, their use must be lim ited. Topical NSAIDs have induced sterile corneal infil trates. 2 Textbooks state that prolonged topical applica tion of local anesthetics is contraindicated 3, 4 because of their inhibition of mitosis and cellular migration. 5 Local anesthetics are said to impair the ability of the corneal epithelium to oxidize glucose and pyruvate. 5 Topical anesthetics can markedly decrease corneal sensation to touch, which is an important corneal protective mecha nism. 6 At commonly encountered concentrations (e.g., 0.5% proparacaine), these agents are also directly toxic to the cornea with prolonged and repeated use, 5,7-9 caus ing increased corneal thickness, opacification, stromal infiltration and punctate epithelial defects. [10] [11] [12] Several publications in the ophthalmology literature have reported that the outpatient use of more dilute topical anesthetics is safe and effective after photo refractive surgery. [13] [14] [15] We asked whether dilute 0.05% proparacaine applied topically would be efficacious in patients with acute corneal injuries discharged from the emergency department. Our primary outcome was pain reduction from baseline as measured on a 10cm visual analog scale. Secondary end points included patient sat isfaction with the study drug, use of medications for breakthrough pain, and signs of delayed wound healing or corneal toxicity on followup.
METHODS

Design
We performed a prospective randomized doubleblind placebocontrolled trial on adults with corneal injuries.
Setting and study population
Our study was performed at 2 tertiary care emergency departments in London, Ont., with a combined census of approximately 120 000 visits per year. We enrolled a convenience sample of adult patients during an 8month period beginning in October 2005. Patients were excluded if they had any of the following: inability to consent to the study, allergy to any of the study med ications, inability to attend followup appointments for any reason, or previous eye injury or pathology.
Interventions
Patients were randomly assigned to groups receiving either 0.05% proparacaine or a colour and smell matched placebo. The usual singledose topical anes thetic used to facilitate eye examination in the partici pating emergency departments is 0.5% proparacaine. Our pharmacy diluted this usual medication 10fold, emulating a previous postoperative study. 15 Patients were instructed to use 2 to 4 drops of the study drug on an asneeded basis for the next 7 days. No minimum time interval between dosing was stipulated, allowing patients unlimited use of the study drug. A total volume of 40 mL was dispensed to each patient.
Participants were given a pain log, topical fluoro quinolone and tablets of 325 mg acetaminophen with 30 mg of codeine for breakthrough pain. Patients received an instruction sheet explaining how to use the pain logs as well as an information sheet explaining the goals of the trial. All patients included in the study were prescribed topical gatifloxacin, 1-2 drops every 2 hours to the affected eye while awake for the dura tion of the study period. They were instructed to take 1 to 2 tablets of the acetaminophen with codeine every 4 hours if needed. Patients were asked to record their use of oral analgesics, and to bring all unused pills to clinic followup appointments, where they were counted.
Outcome measures
Participants were asked to complete the visual analog scale 16 describing their pain immediately before, and 5 minutes after selfadministration of the study drug. On the 10cm scale, 0 indicated "no pain" and 10 indi cated "the worst imaginable pain." The pre and post drug visual analog scales were printed on the same sheet of paper, allowing the participant to see both scales at the time of scoring. The primary outcome was the mean difference in pain scores before and after drug administration as recorded by each study participant. Satisfaction was recorded by participants using a separate 10cm visual analog scale (0 = completely unsatisfied, 10 = completely satisfied).
All patients attended for followup at an outpatient clinic on days 1, 3 and 5 after enrolment by a single oph thalmologist, who was unaware of the patient allocation. The ophthalmologist was directed to identify signs of delayed wound healing, increased corneal thickness, corneal opacification, new corneal epithelial defects or any other ocular pathology that could be related to either the initial injury or the use of study medication. Patients made additional visits thereafter at the discre tion of the observing ophthalmologist. At the final oph thalmology clinic visit, the pain logs were collected.
Patient recruitment
The attending emergency physician and emergency medicine residents on duty recruited patients into the study. The total number of patients eligible for inclu sion in the trial during the 8month trial period was not recorded. No attempt was made to measure the severity of the corneal injury, either in the emergency depart ment or at followup.
Randomization and concealment
Staff at the hospital pharmacy diluted the proparacaine and filled numbered vials with either proparacaine or placebo. These vials were distinguishable only by num ber. The randomization key was generated via a com puter using the random number function of Excel (Microsoft). The lead author and pharmacist were the only 2 people with access to the randomization key. The randomization key was made available to the lead author only after study completion. The contents of the study drug vial were concealed from all personnel involved in patient care, as well as from the patients themselves. Treating physicians were instructed to select the next available vial to dispense to the partici pant at the time of enrolment. The allocation was con firmed by inspection of the numbered vial at followup.
Ethics
Patients provided written consent to the emergency physician at the time of enrolment as approved by our institution's research ethics board.
Statistical analysis
Data were analyzed using SPSS, version 15.0 (SPSS Inc
Sample size
We determined that 16 participants in each group would be needed to have an 80% chance of detecting a pain reduction of 2 cm on the visual analog scale between the 2 groups, assuming an α of 0.05, and a standard devia tion of 2 cm. We chose 2 cm to represent a clinically meaningful difference based on an informal survey of attending emergency physicians at our hospital.
RESULTS
Fifteen participants from the proparacaine group and 18 participants from the placebo group completed the study. Eight enrolled patients either did not use even a ‡Patient satisfaction with the efficacy of study drug recorded by patients at the end of the study, where 0 = not satisfied at all and 10 = completely satisfied. §Median time interval between administration of the first and last drop of study drug for each time the study drug was used. ¶The median number of drops of the study drug that patients self-administered each time the study drug was used. **The median number of tablets of acetaminophen (300 mg) with codeine (30 mg) used after administration of the study drug.
single dose of medication, did not record their pain in their pain logs or were lost to followup. These patients were removed from the trial entirely, and were not included in an intent to treat fashion. The mean age in the proparacaine group was 38.0 years, and in the placebo group was 39.3 years. In the proparacaine group, 87% of participants were male, and in the placebo group 83% were male. All injuries were caused by trauma that had occurred within 24 hours of presentation to the emergency department. Table 1 shows patient outcomes between the 2 groups. Pain reduction 5 minutes after administration of the study drug was significantly better in the propara caine group than in the placebo group (Fig. 1) There was no difference in frequency of administra tion of the study drug between the 2 groups based on pain logs. There were also no ocular complications or evidence of delayed wound healing in either group.
DISCUSSION
Reduction in pain score (VAS, cm) Many physicians receive requests from patients for a topical anesthetic prescription after the initial dose administered in the emergency department provides complete relief. Dogma instructs us to never prescribe outpatient topical anesthesia for corneal injuries. The findings of this study were consistent with those of 3 similar studies in the ophthalmology literature. Each study found that brief outpatient use of dilute top ical anesthetic was safe and effective as an analgesic. [13] [14] [15] The clinically significant differences in pain reduction and patient satisfaction in our study demonstrate the efficacy of diluted proparacaine.
Overall satisfaction (VAS, cm) Although there was a similar time to pain relief in both groups among the patients who achieved pain relief, a small number of patients in the placebo group continued to use rescue oral acetaminophen with codeine tablets for a longer period.
The literature provides examples of corneal toxicity from repeat application of concentrations of anesthetic intended for 1time dosing, [10] [11] [12] generally on the order of 10 times greater than the concentration that we used. Such toxicity has also been described with injected 0.75% bupivacaine, 4% lidocaine, 0.5% proparacaine and 0.5% tetracaine in rabbits. 17 This same rabbit study supports the safety of dilute injected anesthetic agents. An abundance of evidence exists for the toxicity of topi cal anesthetic when abused. [18] [19] [20] [21] [22] [23] [24] We did not observe any evidence of harm from dilutestrength topical anes thetic used for a prescribed duration.
Patients in our study were encouraged to use the drops as frequently as needed. Despite the liberal pre scription of the study drug, both groups administered most of their drops during the first 24 hours. We specu late that patients in the study drug arm achieved ade quate analgesia quickly, and did not require much further analgesic use. Should such patients require anal gesia for only 24 to 36 hours, clinicians could prescribe smaller volumes of anesthetic for a shorter duration, which may further improve safety.
The use of prophylactic topical antibiotics in the uncomplicated corneal injury is controversial and not standard practice in our emergency departments. We added topical antibiotics in consultation with ophthal mology colleagues who participated in the study.
Although our study found no evidence of harm from proparacaine, our patients were dispensed a limited vol ume of dilute anesthetic. Nonetheless, at the end of 5-7 days, all of our patients showed evidence of appropriate injury healing and no patient had continued pain.
Limitations
This study was performed at a single centre and en rolled a small number of patients. It was not powered for important safety outcomes. We had hoped to enrol consecutive patients but suspect that recruiting physi cians missed many eligible patients. No attempt was made to measure the severity or the cause of the corneal injury. We did attempt to verify patient compliance with our protocol by counting remaining tablets, but we did not attempt to measure volume of study drug remaining at followup.
CONCLUSION
Dilute topical anesthetic is an efficacious analgesic in patients with corneal injuries discharged from the emer gency department. Treatment with dilute topical anes thetics may be effective and safe when prescribed for 1 to 2 days. Larger studies powered for safety are neces sary before widespread adoption of this practice.
